Versigent PLC's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters.
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 |
|---|---|---|
| Net sales | $2.4B | $2.2B |
| Cost of sales | $2.1B | $2.0B |
| Selling, general and administrative | $100.0M | $97.0M |
| Amortization | $0 | $1.0M |
| Restructuring (Note 9) | $0 | $46.0M |
| Separation costs | $22.0M | $26.0M |
| Total operating expenses | $2.2B | $2.1B |
| Operating income | $199.0M | $74.0M |
| Interest expense | ($36.0M) | ($5.0M) |
| Other expense, net (Note 18) | ($6.0M) | ($1.0M) |
| Income before income taxes and equity income | $157.0M | $68.0M |
| Income tax expense (Note 13) | ($46.0M) | $9.0M |
| Income before equity income | $111.0M | $77.0M |
| Equity income, net of tax | $5.0M | $4.0M |
| Net income | $116.0M | $81.0M |
| Net (loss) income attributable to noncontrolling interest | ($2.0M) | $3.0M |
| Net income attributable to Versigent | $118.0M | $78.0M |
| Basic earnings per share attributable to Versigent (in usd per share) | $1.66 | — |
| Weighted average number of basic shares outstanding (in shares) | 70.9M | — |
| Diluted earnings per share attributable to Versigent (in usd per share) | $1.64 | — |
| Weighted average number of diluted shares outstanding (in shares) | 71.9M | — |
| Line item | Jun 30, 2026 | Mar 31, 2026 |
|---|---|---|
| Cash and cash equivalents | $554.0M | $282.0M |
| Accounts receivable, net of allowance for doubtful accounts of $18 million and $17 million, respectively (Note 2) | $1.9B | $1.8B |
| Inventories (Note 4) | $772.0M | $784.0M |
| Other current assets (Note 5) | $337.0M | $251.0M |
| Total current assets | $3.5B | $3.1B |
| Property, net | $901.0M | $896.0M |
| Operating lease right-of-use assets | $192.0M | $182.0M |
| Investments in affiliates (Note 6) | $149.0M | $142.0M |
| Intangible assets, net (Note 2) | $6.0M | $7.0M |
| Deferred tax assets | $443.0M | $402.0M |
| Other long-term assets (Note 5) | $128.0M | $134.0M |
| Total long-term assets | $1.8B | $1.8B |
| Total assets | $5.4B | $4.9B |
| Short-term debt (Note 10) | $153.0M | $67.0M |
| Accounts payable | $1.7B | $1.5B |
| Accrued liabilities (Note 7) | $713.0M | $676.0M |
| Total current liabilities | $2.5B | $2.3B |
| Long-term debt (Note 10) | $2.1B | $2.1B |
| Pension benefit obligations | $214.0M | $207.0M |
| Long-term operating lease liabilities | $144.0M | $137.0M |
| Other long-term liabilities (Note 7) | $114.0M | $73.0M |
| Total long-term liabilities | $2.5B | $2.5B |
| Total liabilities | $5.1B | $4.8B |
| Preferred shares, $0.01 par value per share, 50,000,000 shares authorized, none issued and outstanding | $0.00 | — |
| Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 70,925,978 issued and 70,815,717 outstanding as of June 30, 2026 | $1000000.00 | — |
| Additional paid-in-capital | $143.0M | — |
| Retained earnings | $118.0M | — |
| Former Parent’s net investment | $0 | — |
| Accumulated other comprehensive loss (Note 15) | ($177.0M) | ($212.0M) |
| Total Versigent shareholders' equity | $85.0M | ($48.0M) |
| Noncontrolling interest | $199.0M | $191.0M |
| Total shareholders’ equity | $284.0M | $143.0M |
| Total liabilities and shareholders’ equity | $5.4B | $4.9B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 |
|---|---|---|
| Net income | $197.0M | $81.0M |
| Depreciation | $111.0M | $60.0M |
| Amortization | $1.0M | $1.0M |
| Amortization of deferred debt issuance costs | $2.0M | — |
| Restructuring expense, net of cash paid | $9.0M | $20.0M |
| Deferred income taxes | $5.0M | ($7.0M) |
| Pension and other postretirement benefit expenses | $21.0M | $12.0M |
| Income from equity method investments, net of dividends received | ($7.0M) | ($2.0M) |
| Loss on sale of assets | $1.0M | $1.0M |
| Share-based compensation | $19.0M | $8.0M |
| Accounts receivable, net | ($278.0M) | ($151.0M) |
| Inventories | $0 | ($12.0M) |
| Other assets | ($77.0M) | ($10.0M) |
| Accounts payable | $169.0M | $35.0M |
| Accrued and other long-term liabilities | $89.0M | $56.0M |
| Other, net | ($57.0M) | ($51.0M) |
| Pension contributions | ($11.0M) | ($5.0M) |
| Net cash provided by operating activities | $194.0M | $36.0M |
| Capital expenditures | ($117.0M) | ($66.0M) |
| Net cash used in investing activities | ($117.0M) | ($66.0M) |
| Net proceeds (repayments) under short-term debt agreements | $86.0M | $9.0M |
| Net repayments under long-term debt agreements | $0 | — |
| Proceeds from issuance of senior notes and credit agreement, net of issuance costs | $2.1B | $2.1B |
| Cash distribution paid to Former Parent | ($1.9B) | — |
| Net transfers (to) from Former Parent | ($47.0M) | — |
| Dividend payments of consolidated affiliates to minority shareholders | ($4.0M) | ($4.0M) |
| Taxes withheld and paid on employees' restricted share awards | ($1.0M) | — |
| Net cash provided by financing activities | $203.0M | $38.0M |
| Effect of exchange rate fluctuations on cash and cash equivalents | ($2.0M) | ($2.0M) |
| Increase in cash and cash equivalents | $278.0M | $6.0M |
| Cash and cash equivalents at beginning of the period | $276.0M | $276.0M |
| Cash and cash equivalents at end of the period | $554.0M | $282.0M |
| Capital expenditures included in accounts payable | $40.0M | $39.0M |
Versigent PLC score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.